The short version
A genetic headline is only as strong as the study behind it. Six questions sort strong claims from weak ones in about a minute. This page gives you the questions, a table of study types, and two worked examples.
The usual mix-up
"A study found a link between gene X and ADHD" sounds like "gene X causes ADHD". It almost never means that. "Associated with" is a statistical statement about groups. It needs a sample size, a replication and an effect size before it means much.
The six questions
- What kind of study is it? (table below)
- How many people? Small samples give unstable results.
- Has anyone else found the same thing? Replication is the single best guard against false leads.
- How big is the effect? "Significant" is not the same as "large".
- Who was studied? Children or adults? One ancestry group? Blood cells or brain?
- What does the claim say it means? "Associated with" is fine. "Causes" needs far more.
Study types at a glance
| Study type | What it can tell you | What it cannot tell you | Watch for |
|---|---|---|---|
| Twin / family | How much of the variation in a trait is genetic | Which genes | Treating heritability as "share of your condition" |
| Candidate-gene | Whether a pre-chosen gene differs between groups | Anything outside the chosen genes | Small samples, conflicting results across studies |
| GWAS | Regions of common DNA variation linked to a trait across the whole genome | The causal gene or mechanism in each region | Reading "nearest gene" as "cause" |
| Sequencing (exome or genome) | Rare variants, including new ones in a child | Effects of common variants | Small trios, overclaiming one gene |
| Peripheral marker (e.g. blood platelets) | A cheap proxy that might reflect brain biology | Whether the brain differs in the same way | "It's in the blood so it's in the brain" |
| Animal or cell model | Whether a mechanism is possible | Whether it operates in human ADHD | Generalising from mice |
| Case report | That a rare pattern exists | How common it is | One case treated as a rule |
Worked example 1: a candidate-gene meta-analysis
A 2009 meta-analytic review pooled earlier candidate-gene studies of childhood ADHD. It found significant associations for several genes, including DAT1, DRD4, DRD5, 5HTT, HTR1B and SNAP25. It also found significant heterogeneity for many of them, meaning the results differed from study to study [1].
How to read it: a real finding, at its time, from pre-chosen genes, with conflicting results between studies. It is a reason to keep looking, not a reason to call any of these "the ADHD gene". Later genome-wide studies use a different design [2, 3]. Do not quote the 2009 list as if it were the modern GWAS result.
Worked example 2: a small blood-platelet study
A 2005 study measured binding to the vesicular monoamine transporter (VMAT2) in blood platelets from 11 untreated boys and adolescents with ADHD and 14 controls. Binding capacity was 17% lower in the ADHD group, and lower binding went with higher symptom scores. The authors state that it is unclear whether platelet VMAT2 reflects the brain, and whether the difference is primary or a by-product [4].
How to read it: Tier C. Small, single study, children only, a peripheral proxy, and the authors' own caution. It justifies the question "is vesicle packaging involved in ADHD?" It does not answer it.
A safe sentence template
> A [study type] in [who, how many] found [what], which has [been / not yet been] replicated.
If you cannot fill all four blanks, the claim is not ready to be stated as fact.
Limits
- This is a reading guide, not a verdict on any individual paper.
- The two worked examples were chosen because they show common pitfalls, not because they are the best or worst studies.
Sources
Bibliographic details checked against PubMed.
- Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009;126(1):51-90. DOI · PMID 19506906
- Demontis D et al. Nat Genet 2023. DOI · PMID 36702997
- van der Laan CM et al. Nat Genet 2025;57(10):2427-2435. DOI · PMID 40962958
- Toren P et al. Decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder. Eur Neuropsychopharmacol 2005;15(2):159-162. DOI · PMID 15695060